Transcat, Inc. (NASDAQ:TRNS) Shares Purchased by Royce & Associates LP

Royce & Associates LP increased its holdings in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) by 1.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 478,581 shares of the scientific and technical instruments company's stock after acquiring an additional 5,327 shares during the quarter. Royce & Associates LP owned about 5.14% of Transcat worth $35,630,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of TRNS. Conestoga Capital Advisors LLC raised its stake in Transcat by 5.8% during the first quarter. Conestoga Capital Advisors LLC now owns 957,254 shares of the scientific and technical instruments company's stock worth $71,268,000 after purchasing an additional 52,328 shares during the period. Neuberger Berman Group LLC raised its stake in Transcat by 1.8% during the fourth quarter. Neuberger Berman Group LLC now owns 873,985 shares of the scientific and technical instruments company's stock worth $92,415,000 after purchasing an additional 15,723 shares during the period. Champlain Investment Partners LLC raised its stake in Transcat by 35.7% during the fourth quarter. Champlain Investment Partners LLC now owns 555,650 shares of the scientific and technical instruments company's stock worth $58,754,000 after purchasing an additional 146,150 shares during the period. T. Rowe Price Investment Management Inc. raised its stake in Transcat by 178.0% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 518,597 shares of the scientific and technical instruments company's stock worth $54,837,000 after purchasing an additional 332,064 shares during the period. Finally, Geode Capital Management LLC raised its stake in shares of Transcat by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 219,354 shares of the scientific and technical instruments company's stock valued at $23,200,000 after acquiring an additional 1,881 shares during the period. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Stock Down 1.7%

NASDAQ TRNS traded down $1.44 on Monday, hitting $82.71. 45,830 shares of the stock were exchanged, compared to its average volume of 107,545. The company has a 50-day moving average price of $84.29 and a 200-day moving average price of $82.35. Transcat, Inc. has a fifty-two week low of $67.56 and a fifty-two week high of $141.27. The company has a quick ratio of 1.87, a current ratio of 2.29 and a debt-to-equity ratio of 0.11. The company has a market cap of $770.69 million, a PE ratio of 53.02 and a beta of 0.73.

Transcat (NASDAQ:TRNS - Get Free Report) last issued its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.66 by ($0.02). Transcat had a net margin of 5.21% and a return on equity of 6.47%. The company had revenue of $77.13 million during the quarter, compared to analyst estimates of $76.40 million. The business's revenue for the quarter was up 8.8% on a year-over-year basis. Sell-side analysts anticipate that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

TRNS has been the topic of a number of research analyst reports. HC Wainwright reissued a "buy" rating and issued a $116.00 price target on shares of Transcat in a research note on Wednesday, June 25th. Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday, May 28th. Finally, Lake Street Capital started coverage on shares of Transcat in a research note on Thursday, July 10th. They set a "buy" rating and a $105.00 target price on the stock. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $112.20.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.